Featured News for ProPharma Group Kansas Office

August 31, 2013

New ProPharma office building in Overland Park, Kansas City

Due in large part to the continued support from our loyal clients, ProPharma Group has officially outgrown our existing Kansas location and has relocated to a larger office in Overland Park, Kansas! As of September 1, 2013, our new address is:

ProPharma Group, Inc.
8717 W 110th Street, Suite 300
Overland Park, KS 66210

In addition to expanding our walls, we are also celebrating being named one of Kansas City’s Top Area Animal Health Companies by the Kansas City Business Journal this past August.  In our first ever appearance in this list, ProPharma Group ranked 10 out of 23 featured companies based on full-time equivalent employees in the Kansas City Area. We are not only proud to be listed, but also proud of the progress we are making to support more and more of the growing animal health community.

A big thank you goes out to all of our clients for supporting ProPharma Group and helping us achieve new goals each and every day. 

TAGS:

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

November 25, 2014

Matthew Weinberg Quoted in Article about EMA’s Initiative to Broaden Expert Involvement with Updated Policy on Conflicts of Interest

FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...

January 28, 2019

ProPharma Group Acquires The Weinberg Group

ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...